New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
24 oct. 2024 08h30 HE
|
FirstFitness Nutrition
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Side Effects Offering a Natural GLP-1 Alternatative for Weight Loss.
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
22 oct. 2024 09h54 HE
|
Elevai Labs Inc.
Elevai Biosciences Engages Leading CRO to Support Regulatory Planning Efforts and Pre-IND Meeting with the FDA for EL-22 For The Treatment of Obesity
Weight Management Report 2024: Consumer Mindsets & Actions - Market-Level Nuances on Weight, Dieting and Exercise
22 oct. 2024 07h42 HE
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Weight Management: Consumer Mindsets & Actions - Market-Level Nuances on Weight, Dieting, & Exercise" report has been added to ...
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
21 oct. 2024 07h30 HE
|
Elevai Labs Inc.
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Bl
Sesame, America’s Low-Cost Leader in Healthcare, Is First Major Direct-to-Consumer Weight Loss Company to Offer Compounded Semaglutide to All 50 United States
16 oct. 2024 08h05 HE
|
Sesame
NEW YORK CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Sesame, the company that offers Americans quality, convenient health care at half the typical price, today announced that it has begun offering...
Canada Weight Management and Wellbeing Market Analysis, 2019-2028: Developments, Trends, Opportunities, Shares, Sales, and Growth Forecasts
16 oct. 2024 05h48 HE
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Weight Management and Wellbeing in Canada" report has been added to ResearchAndMarkets.com's offering.Weight management and wellbeing is set to see...
Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More
15 oct. 2024 12h54 HE
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Services Market Size, Share and Trends Analysis Report by Function (Fitness Equipment, Surgical Equipment, Services), Payment...
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
08 oct. 2024 09h00 HE
|
WW International Inc.
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering,...
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients, Including GLP-1 Receptor Agonist Combinations
03 oct. 2024 07h30 HE
|
Elevai Labs Inc.
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Expands Patent Portfolio with Two New Filings for EL-22 in Muscle Loss Treatment for Obese Patients,
Safe, Personalized, and Affordable Weight Loss Care for Community Heroes
02 oct. 2024 11h30 HE
|
D S Simon
NEW YORK, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The public health crisis of obesity in America continues to grow – over 100 million Americans struggle with weight-related challenges and 1 in 6 deaths...